In the world of oncology, genomic data has become a cornerstone of precision medicine. From identifying targetable mutations to matching patients with clinical trials, molecular testing has revolutionized how we approach cancer treatment. But there's a challenge that many cancer centers and research institutions face daily: the data coming from different genomic testing vendors is anything but standardized.